Company profile for GPCR Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GPCR Therapeutics, Inc. is a venture-backed, clinical stage international biopharmaceutical company with an innovative approach to developing therapeutics built on its proprietary GPCR data. The company’s proprietary data-driven approach has identified over 1000 GPCR pairs upon which drug screening campaigns can be pursued. Identification of the best GPCR pair to target for specific disease indications and patient subpopulat...
GPCR Therapeutics, Inc. is a venture-backed, clinical stage international biopharmaceutical company with an innovative approach to developing therapeutics built on its proprietary GPCR data. The company’s proprietary data-driven approach has identified over 1000 GPCR pairs upon which drug screening campaigns can be pursued. Identification of the best GPCR pair to target for specific disease indications and patient subpopulations creates a personalized approach to combination therapy. By targeting the unique pharmacology of GPCR pairs, we aim to develop life changing treatments for cancer and other diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
Room 407, Nakseongdae R&D Center 38, Nakseongdae-ro, Gwanak-gu, Seoul 08790
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250122516457/en

BUSINESSWIRE
23 Jan 2025

https://www.businesswire.com/news/home/20241226044292/en

BUSINESSWIRE
27 Dec 2024

https://www.businesswire.com/news/home/20240401049241/en

BUSINESSWIRE
01 Apr 2024

https://www.globenewswire.com//news-release/2023/12/14/2796008/0/en/GPCR-Therapeutics-Announces-Out-Licensing-Agreement-with-Bridge-Biotherapeutics-in-Idiopathic-Pulmonary-Fibrosis.html

GLOBENEWSWIRE
14 Dec 2023

https://www.globenewswire.com//news-release/2023/10/26/2767175/0/en/GPCR-Therapeutics-Announces-Publication-on-Improving-Hematopoietic-Stem-Cell-Mobilization-Using-Propranolol-with-GPC-100.html

GLOBENEWSWIRE
26 Oct 2023

https://www.globenewswire.com//news-release/2023/10/10/2757153/0/en/GPCR-Therapeutics-Expands-Pipeline-into-Fibrosis-with-a-Combination-Approach-Targeting-LPA1.html

GLOBENEWSWIRE
10 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty